SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-318636
Filing Date
2020-12-16
Accepted
2020-12-16 08:52:59
Documents
9
Period of Report
2021-01-27
Effectiveness Date
2020-12-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d50382ddef14a.htm DEF 14A 747551
2 GRAPHIC g50382dsp069.jpg GRAPHIC 3398
3 GRAPHIC g50382dsp2.jpg GRAPHIC 10059
4 GRAPHIC g50382dsp67.jpg GRAPHIC 3584
5 GRAPHIC g50382dsp67a.jpg GRAPHIC 4872
6 GRAPHIC g50382dsp68.jpg GRAPHIC 3518
7 GRAPHIC g50382dsp69.jpg GRAPHIC 3517
8 GRAPHIC g50382gr01.jpg GRAPHIC 9232
9 GRAPHIC g50382page35.jpg GRAPHIC 2175
  Complete submission text file 0001193125-20-318636.txt   799997
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 201391386
SIC: 2835 In Vitro & In Vivo Diagnostic Substances